Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): Predictive role of minimal residual disease monitoring on relapse

M. Miglino, G. Berisso, R. Grasso, L. Canepa, M. Clavio, I. Pierri, D. Pietrasanta, S. Gatto, R. Varaldo, F. Ballerini, S. Verdiani, L. Casarino, F. DeStefano, M. Sessarego, A. Dominietto, A. M. Raiola, S. Bregante, C. di Grazia, M. Gobbi, A. Bacigalupo

Research output: Contribution to journalArticle

Abstract

We developed a PCR-based method to monitor clonogenic IgH VDJ rearrangement as a possible predictor of relapse in patients with acute B-ALL after allogeneic bone marrow transplantation (BMT). We studied 23 patients at diagnosis, before and after BMT. At the time of BMT, 13 patients were in first complete remission, eight in second complete remission and two in relapse. Four patients were PCR negative before BMT and remained PCR negative also after BMT (-/- pattern). They are still in remission after a median follow-up of 41 months. Nineteen patients were MRD-positive before BMT: three were PCR negative at first determination after BMT (+/- pattern) and maintain remission. Sixteen patients were PCR-positive at first determination after BMT (+/+ pattern): five became PCR negative (+/+/- pattern) (four with chronic graft-versus-host disease (GVHD) and two after donor lymphocyte infusions (DLI)). Nine patients remained PCR-positive (+/+/+ pattern) (four remain in remission, and six relapsed); two patients died before transplant. In conclusion, PCR negative patients before BMT remained negative post-BMT; many pre-BMT positive patients had initial MRD positivity after BMT: 37% of them achieved a molecular remission with cGVHD or DLI.

Original languageEnglish
Pages (from-to)579-585
Number of pages7
JournalBone Marrow Transplantation
Volume30
Issue number9
DOIs
Publication statusPublished - Nov 2002

Fingerprint

Homologous Transplantation
Residual Neoplasm
Bone Marrow Transplantation
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Recurrence
Polymerase Chain Reaction
Tissue Donors
Lymphocytes
Graft vs Host Disease

Keywords

  • Acute lymphoblastic leukemia
  • Allogeneic bone marrow transplantation
  • MRD
  • PCR

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL) : Predictive role of minimal residual disease monitoring on relapse. / Miglino, M.; Berisso, G.; Grasso, R.; Canepa, L.; Clavio, M.; Pierri, I.; Pietrasanta, D.; Gatto, S.; Varaldo, R.; Ballerini, F.; Verdiani, S.; Casarino, L.; DeStefano, F.; Sessarego, M.; Dominietto, A.; Raiola, A. M.; Bregante, S.; di Grazia, C.; Gobbi, M.; Bacigalupo, A.

In: Bone Marrow Transplantation, Vol. 30, No. 9, 11.2002, p. 579-585.

Research output: Contribution to journalArticle

Miglino, M. ; Berisso, G. ; Grasso, R. ; Canepa, L. ; Clavio, M. ; Pierri, I. ; Pietrasanta, D. ; Gatto, S. ; Varaldo, R. ; Ballerini, F. ; Verdiani, S. ; Casarino, L. ; DeStefano, F. ; Sessarego, M. ; Dominietto, A. ; Raiola, A. M. ; Bregante, S. ; di Grazia, C. ; Gobbi, M. ; Bacigalupo, A. / Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL) : Predictive role of minimal residual disease monitoring on relapse. In: Bone Marrow Transplantation. 2002 ; Vol. 30, No. 9. pp. 579-585.
@article{b761995e71fc441b93b95d9d02389ef0,
title = "Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): Predictive role of minimal residual disease monitoring on relapse",
abstract = "We developed a PCR-based method to monitor clonogenic IgH VDJ rearrangement as a possible predictor of relapse in patients with acute B-ALL after allogeneic bone marrow transplantation (BMT). We studied 23 patients at diagnosis, before and after BMT. At the time of BMT, 13 patients were in first complete remission, eight in second complete remission and two in relapse. Four patients were PCR negative before BMT and remained PCR negative also after BMT (-/- pattern). They are still in remission after a median follow-up of 41 months. Nineteen patients were MRD-positive before BMT: three were PCR negative at first determination after BMT (+/- pattern) and maintain remission. Sixteen patients were PCR-positive at first determination after BMT (+/+ pattern): five became PCR negative (+/+/- pattern) (four with chronic graft-versus-host disease (GVHD) and two after donor lymphocyte infusions (DLI)). Nine patients remained PCR-positive (+/+/+ pattern) (four remain in remission, and six relapsed); two patients died before transplant. In conclusion, PCR negative patients before BMT remained negative post-BMT; many pre-BMT positive patients had initial MRD positivity after BMT: 37{\%} of them achieved a molecular remission with cGVHD or DLI.",
keywords = "Acute lymphoblastic leukemia, Allogeneic bone marrow transplantation, MRD, PCR",
author = "M. Miglino and G. Berisso and R. Grasso and L. Canepa and M. Clavio and I. Pierri and D. Pietrasanta and S. Gatto and R. Varaldo and F. Ballerini and S. Verdiani and L. Casarino and F. DeStefano and M. Sessarego and A. Dominietto and Raiola, {A. M.} and S. Bregante and {di Grazia}, C. and M. Gobbi and A. Bacigalupo",
year = "2002",
month = "11",
doi = "10.1038/sj.bmt.1703659",
language = "English",
volume = "30",
pages = "579--585",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL)

T2 - Predictive role of minimal residual disease monitoring on relapse

AU - Miglino, M.

AU - Berisso, G.

AU - Grasso, R.

AU - Canepa, L.

AU - Clavio, M.

AU - Pierri, I.

AU - Pietrasanta, D.

AU - Gatto, S.

AU - Varaldo, R.

AU - Ballerini, F.

AU - Verdiani, S.

AU - Casarino, L.

AU - DeStefano, F.

AU - Sessarego, M.

AU - Dominietto, A.

AU - Raiola, A. M.

AU - Bregante, S.

AU - di Grazia, C.

AU - Gobbi, M.

AU - Bacigalupo, A.

PY - 2002/11

Y1 - 2002/11

N2 - We developed a PCR-based method to monitor clonogenic IgH VDJ rearrangement as a possible predictor of relapse in patients with acute B-ALL after allogeneic bone marrow transplantation (BMT). We studied 23 patients at diagnosis, before and after BMT. At the time of BMT, 13 patients were in first complete remission, eight in second complete remission and two in relapse. Four patients were PCR negative before BMT and remained PCR negative also after BMT (-/- pattern). They are still in remission after a median follow-up of 41 months. Nineteen patients were MRD-positive before BMT: three were PCR negative at first determination after BMT (+/- pattern) and maintain remission. Sixteen patients were PCR-positive at first determination after BMT (+/+ pattern): five became PCR negative (+/+/- pattern) (four with chronic graft-versus-host disease (GVHD) and two after donor lymphocyte infusions (DLI)). Nine patients remained PCR-positive (+/+/+ pattern) (four remain in remission, and six relapsed); two patients died before transplant. In conclusion, PCR negative patients before BMT remained negative post-BMT; many pre-BMT positive patients had initial MRD positivity after BMT: 37% of them achieved a molecular remission with cGVHD or DLI.

AB - We developed a PCR-based method to monitor clonogenic IgH VDJ rearrangement as a possible predictor of relapse in patients with acute B-ALL after allogeneic bone marrow transplantation (BMT). We studied 23 patients at diagnosis, before and after BMT. At the time of BMT, 13 patients were in first complete remission, eight in second complete remission and two in relapse. Four patients were PCR negative before BMT and remained PCR negative also after BMT (-/- pattern). They are still in remission after a median follow-up of 41 months. Nineteen patients were MRD-positive before BMT: three were PCR negative at first determination after BMT (+/- pattern) and maintain remission. Sixteen patients were PCR-positive at first determination after BMT (+/+ pattern): five became PCR negative (+/+/- pattern) (four with chronic graft-versus-host disease (GVHD) and two after donor lymphocyte infusions (DLI)). Nine patients remained PCR-positive (+/+/+ pattern) (four remain in remission, and six relapsed); two patients died before transplant. In conclusion, PCR negative patients before BMT remained negative post-BMT; many pre-BMT positive patients had initial MRD positivity after BMT: 37% of them achieved a molecular remission with cGVHD or DLI.

KW - Acute lymphoblastic leukemia

KW - Allogeneic bone marrow transplantation

KW - MRD

KW - PCR

UR - http://www.scopus.com/inward/record.url?scp=0036859817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036859817&partnerID=8YFLogxK

U2 - 10.1038/sj.bmt.1703659

DO - 10.1038/sj.bmt.1703659

M3 - Article

C2 - 12407432

AN - SCOPUS:0036859817

VL - 30

SP - 579

EP - 585

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 9

ER -